Quantitative assay for evaluating immunocompetence and DNA repair capacity

Area of Science:

• Immunology
• Molecular Biology
• Cancer Research

Background:

• Radioactive thymidine incorporation into DNA is a common method to assess immunosuppression in cancer patients and DNA repair in damaged cells.
• Current assays for human lymphocytes exhibit unreliability, potentially leading to inaccurate conclusions regarding immune and DNA repair capacities.

Purpose of the Study:

• To develop a modified assay for accurate and reliable measurement of immunocompetence and DNA repair capacity in human cells.
• To enable comparative studies between individuals and assess the impact of biological response modifiers.

Main Methods:

• Modification of the standard radioactive thymidine incorporation assay.
• Utilizing autologous plasma for cell studies to improve assay accuracy.
• Application to human lymphocytes and potentially other cell types.

Main Results:

• The modified assay provides reliable comparisons of immunocompetence and DNA repair capacity.
• The assay is suitable for studying cells in their native plasma environment.
• Facilitates assessment of biological response modifiers' effects on immune and repair functions.

Conclusions:

• The developed assay offers a more accurate method for evaluating immune function and DNA repair.
• This improved assay is valuable for research in cancer immunology and toxicology.
• The use of autologous plasma enhances the physiological relevance of the cellular assays.